Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- S&P 500, Nasdaq eye tepid open as Middle East tensions weigh
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Mizuho survey highlights upside in this MedTech stock
June 17, 2025 3:00 PM EDTThe renal denervation (RDN) platform could drive transformational growth for one medtech firm, according to a new Mizuho survey of cardiologists treating drug-resistant hypertension.
The analysts upgraded their outlook for Medtronic (NYSE: MDT) after results indicated strong enthusiasm for RDN and a clear lead for Medtronics Symplicity Spyral System over rival Recor Medical.
We conducted a snap poll... More
